Abstract
Roentgenographically occult bronchogenic squamous cell carcinomas are early lung cancers that localize in the bronchial wall, and are thought to be a good model to elucidate the carcinogenesis of lung cancer. In the present study, we analyzed the incidence of allelic losses on chromosome regions 3p21 and 17p13 in 40 cases of roentgenographically occult bronchogenic squamous cell carcinomas, using three microsatellite dinucleotide polymorphic markers. We also investigated the relationship between such allelic loss and the clinicopathological findings of those cases. These chromosome regions showed frequent losses. Moreover, the incidence of loss on 17p13 increased gradually along with the advance of the depth of invasion, while the incidence of loss on 3p21 increased along with the advancing length of the longitudinal extension. These results suggested that these chromosome regions play different roles in lung cancer progression, i.e., the 3p21 chromosome region was related to the longitudinal extension of the carcinoma while the 17p13 (p53) region was related to the depth of invasion.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
1. Tsuchiya E, Nakamura Y, Weng S, Nakagawa K, Tsuchiya S, Sugano H, Kitagawa T (1992) Allelotype of non-small cell lung carcinoma — comparison between loss of heterozygosity in squamous cell carcinoma and adenocarcinoma. Cancer Res 52:2478–2481
2. Thiberville L, Bourguignon J, Metayer J, Bost F, Diarra-Mehrpour M, Bignon J, Lam S, Martin JP, Nouvet G (1995) Frequency and prognostic evaluation of 3p21–22 allelic losses in non-small-cell lung cancer. Int J Cancer (Pred Oncol) 64:371–377
3. Shiseki M, Kohno T, Nishikawa R, Sameshima Y, Mizoguchi H, Yokota J (1994) Frequent allelic losses on chromosomes 2q, 18q, and 22q in advanced non-small cell lung carcinoma. Cancer Res 54:5643–5648
4. Thiberville L, Payne P, Vielkinds J, LeRiche J, Horsman D, Nouvet G, Palcic B, Lam S (1995) Evidence of cumulative gene losses with progression of premalignant epithelial lesions to carcinoma of the bronchus. Cancer Res 55:5133–5139
5. Sundaresan V, Ganly P, Hasleton P, Rudd R, Sinha G, Bleehen NM, Rabbits P (1992) p53 and chromosome 3 abnormalities, char acteristic of malignant lung tumours, are detectable in preinvasive lesions of the bronchus. Oncogene 7:1989–1997
6. Hung J, Kishimoto Y, Sugio K, Virmani A, McIntire D, Minna JD, Gazdar AF (1995) Allele-specific chromosome 3p deletions occur at an early stage in the pathogenesis of lung carcinoma. JAMA 273:558–563
7. Chung Y, Sundaresan Y, Hasleton P, Rudd R, Taylor R, Rabbits PH (1995) Sequential molecular genetic changes in lung cancer development. Oncogene 11:2591–2598
8. Saito Y, Nagamoto N, Ota S, Sato M, Sagawa M, Kanma K, Takahashi S, Usuda K, Endo C, Imai T, Fujimura S (1992) Results of surgical treatment to roentgenographically occult bronchogenic squamous cell carcinoma. J Thorac Cardiovasc Surg 104:401–407
9. Saito Y, Nagamoto N, Ota S, Sato M, Kanma K, Takahashi S, Fujimura S, Imai T (1990) Comparison of resected and nonresected cases of roentgenographically occult bronchogenic squamous cell carcinoma (in Japanese). Jpn J Lung Cancer 30:547–554
10. Nagamoto N, Saito Y, Suda H, Imai T, Sato M, Ohta S, Kanma K, Sagawa M, Takahashi S, Usuda K, Nakada T, Sato H, Hashimoto K (1989) Relationship between length of longitudinal extension and maximal depth of transmural invasion in roentgenographically occult squamous cell carcinoma of the bronchus (nonpolypoid type). Am J Surg Pathol 13:11–20
11. Nagamoto N, Saito Y, Sato M, Sagawa M, Kanma K, Takahashi S, Usuda K, Endo C, Fujimura S, Nakada T, Ohkuda K (1993) Clinicopathological analysis of 19 cases of isolated carcinoma in situ of the bronchus. Am J Surg Pathol 17:1234–1243
12. Monica H, Sidransky D, Vogelstein B, Harris CC (1991) p53 mutations in human cancers. Science 253:49–53
13. Sozzi G, Miozzo M, Donghi R, Pilotti S, Cariani CT, Pastorino U, Porta GD, Pierotti MA (1992) Deletions of 17p and p53 mutations in preneoplastic lesions of the lung. Cancer Res 52:6079–6082
14. Ieda S, Watatani M, Yoshida T, Kuroda K, Inui H, Yasutomi M (1996) Immunohistochemical analysis of p53 and ras p21 expression in colorectal adenomas and early carcinomas. Surg Today 26:230–235
15. Kieser A, Weich HA, Brandner G, Marme D, Kolch W (1994) Mutant p53 potentiates protein kinase C induction of vascular endothelial growth factor expression. Oncogene 9:963–969
16. Mukhopadhyay D, Tsiokas L, Sukhatme VP (1995) Wild-type p53 and v-Src exert opposing influences on human vascular endothelial growth factor gene expression. Cancer Res 55:6161–6165
17. Wei MH, Latif F, Bader S, Kashuda Y, Chen Y, Duh FM, Sekido Y, Lee CC, Geil L, Kuzmin I, Zabarovsky E, Klein G, Zbar B, Minna JD, Lerman M (1996) Construction of a 600-kilobase cosmid clone contig and generation of a transcriptional map surrounding the lung cancer tumor suppressor gene (TSG) locus on human chromosome 3p21.3: progress toward the isolation of a lung cancer TSG. Cancer Res 56:1487–1492
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Endo, C., Sato, M., Fujimura, S. et al. Allelic loss on 17p13 (TP53) and allelic loss on 3p21 in early squamous cell carcinoma of the lung. Surg Today 30, 695–699 (2000). https://doi.org/10.1007/s005950070079
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s005950070079